10.72USD-0.74%Mkt Cap: 779.12M USDP/E: 9.44Last update: 2026-06-01
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead p…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap779.12M USD
Enterprise Value890.31M USD
Revenue (TTM)9.89M USD
Gross Profit-18.84M USD
Net Income (TTM)-3.35M USD
Revenue/Share0.1480 USD
Last Price10.72 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees175
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6821431029
Valuation
P/E (Trailing)9.44
P/E (Forward)-368.00
PEG0.81
EV/EBITDA-8.53
EV/Revenue89.99
P/S80.77
P/B-6.53
EPS (TTM)1.14
EPS (Forward)-0.03
52W Range
2.95053% of range17.65
52W High17.65 USD
52W Low2.950 USD
Profitability
Gross Margin-190.49%
Oper. Margin-176.09%
EBITDA Margin0.00%
Profit Margin871.02%
ROE2.76%
ROA-1.03%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-116.09M USD
CapEx (TTM)65.00K USD
FCF Margin1829.74%
FCF Yield23.23%
Net Debt91.29M USD
Net Debt/EBITDA-0.87
Balance Sheet
Debt/Equity-1.97
Current Ratio3.03
Quick Ratio2.48
Book Value/Sh-1.6910 USD
Cash/Share1.870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)40.00 USD
Target Range40.00 USD – 40.00 USD
# Analysts1
Ownership
Shares Out.72.38M
Float69.80M
Insiders3.56%
Institutions44.41%
Short Interest
Short Ratio11.9d
Short % Float22.84%
Short % Out.22.02%
Shares Short15.94M
Short (prev mo.)16.90M
Technical
SMA 5012.45 (-13.9%)
SMA 2009.680 (+10.7%)
Beta2.66
S&P 52W Chg27.94%
Avg Vol (30d)1.35M
Avg Vol (10d)2.05M
Technical Indicators
RSI (14)35.5
MACD-0.5968
MACD Signal-0.2473
MACD Hist.-0.3495
BB Upper16.24 USD
BB Middle13.05 USD
BB Lower9.872 USD
BB Width48.77%
ATR (14)0.7421 USD
Vol Ratio (20d)0.52x